Literature DB >> 15573626

Expression of E-cadherin in human colorectal cancer.

M A Khoursheed1, T C Mathew, R R Makar, S Louis, S K Asfar, H M Al-Sayer, H M Dashti, A Al-Bader.   

Abstract

AIM: To investigate the expression of E-cadherin, a calcium-dependent cell-cell adhesion molecule in colorectal carcinoma. Antibodies to E-Cadherin were used to establish the association of their expression with the clinicopathological characteristics of this disease using immunohistochemical methods.
METHODS: Immunohistochemical analysis for E-cadherin was carried out in formalin-fixed, paraffin-embedded sections of neoplastic colorectal tissues and non-neoplastic ones adjacent to the lesion from 49 patients who underwent surgery, by the standard peroxidase-antiperoxidase method. Expression of this antigen in normal and malignant epithelium and stromal cells was compared.
RESULTS: Both neoplastic and normal tissues showed expression of E-cadherin. There was, however, higher expression of E-cadherin in epithelial cells in both tumour and normal tissues than stromal cells. The percentage of expression in epithelial cells of well-differentiated tumours was significantly higher than moderately differentiated tumours. Loss of normal membranous expression and the presence of cytoplasmic and mixed staining were found frequently in tumour tissues (p = 0.004). This loss of membranous expression, however, did not correlate with Duke's staging, tumour grade, sex, size or site of the tumour.
CONCLUSION: This study suggests that the lower expression of E-cadherin in less differentiated tumours may explain their aggressive nature, although loss of membranous expression was not significantly correlated to Duke's staging, tumour grade, sex, size and site of tumour.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15573626     DOI: 10.1016/s1479-666x(03)80121-x

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  6 in total

1.  E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

Authors:  Adam Elzagheid; Annika Algars; Riyad Bendardaf; Hanan Lamlum; Raija Ristamaki; Yrjo Collan; Kari Syrjanen; Seppo Pyrhonen
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

2.  Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma.

Authors:  Abd Al-Rahman Mohammad Foda; Mie Ali Mohammad; Azza Abdel-Aziz; Amira Kamal El-Hawary
Journal:  Tumour Biol       Date:  2015-01-27

3.  An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1.

Authors:  Zsuzsanna Pap; Zoltán Pávai; Lóránd Dénes; Ilona Kovalszky; János Jung
Journal:  Pathol Oncol Res       Date:  2009-03-01       Impact factor: 3.201

4.  E-cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases.

Authors:  Petra Jurčić; Petra Radulović; Melita Perić Balja; Milan Milošević; Božo Krušlin
Journal:  Oncol Lett       Date:  2019-01-10       Impact factor: 2.967

Review 5.  E-cadherin Beyond Structure: A Signaling Hub in Colon Homeostasis and Disease.

Authors:  Amanda C Daulagala; Mary Catherine Bridges; Antonis Kourtidis
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

6.  Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma.

Authors:  Sharmilla Devi Rajkumar; Barathi Gunabooshanam; Leena Dennis Joseph; Lawrence D'Cruze
Journal:  Prz Gastroenterol       Date:  2021-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.